We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

HBM Healthcare Investments AG (HBMN) CHF41.80

Sell:187.60 CHF Buy:188.80 CHF Change: 0.40 CHF (0.21%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:187.60 CHF
Buy:188.80 CHF
Change: 0.40 CHF (0.21%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:187.60 CHF
Buy:188.80 CHF
Change: 0.40 CHF (0.21%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Contact details

Address:
Bundesplatz 1
ZUG
6300
Switzerland
Telephone:
+41 (41) 7107577
Website:
https://www.hbmhealthcare.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HBMN
ISIN:
CH0012627250
Market cap:
1.31 billion CHF
Shares in issue:
6.91 million
Sector:
Asset Management & Custody Banks
Exchange:
SIX Swiss Exchange
Country:
Switzerland
Currency:
Swiss Franc
Indices:
Swiss All Share Index

Key personnel

  • Hans Hasler
    Chairman of the Board
  • Andreas Wicki
    Chief Executive Officer
  • Erwin Troxler
    Chief Financial Officer
  • Benedikt Suter
    Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.